| The Spatial Extracellular Proteomic Tumor Microenvironment Distinguishes Molecular Subtypes of Hepatocellular Carcinoma JK Macdonald, HB Taylor, M Wang, A Delacourt, C Edge, DN Lewin, ... Journal of Proteome Research, 2024 | | 2024 |
| Multiplexed immunohistochemical analysis of the immune microenvironment of biliary tract cancers pre-& post-neoadjuvant chemotherapy: case series S Dharmapuri, R Cabal, G Akturk, G Ioannou, S Ozbey, J Paulsen, ... Annals of Translational Medicine, 2024 | | 2024 |
| Nodular number as a prognostic indicator in hepatic resection for intermediate-stage hepatocellular carcinoma: An international multicenter observational study. H Liu, ZQ Fan, MD Wang, M Serenari, M Schwartz, Z Chen, YH Zhou, ... Journal of Clinical Oncology 42 (16_suppl), e16271-e16271, 2024 | | 2024 |
| 1052 PAAM FOR HEPATOCELLULAR CARCINOMA RISK STRATIFICATION IN PATIENTS WITH CIRRHOSIS: MULTICENTER PHASE 3 BIOMARKER VALIDATION STUDIES IN THE US N Fujiwara, C Lopez, TL Marsh, I Raman, CA Marquez, S Paul, SK Mishra, ... Gastroenterology 166 (5), S-1563, 2024 | | 2024 |
| Immunotherapy and transplantation for hepatocellular carcinoma P Tabrizian, M Abdelrahim, M Schwartz Journal of Hepatology 80 (5), 822-825, 2024 | 4 | 2024 |
| Improved outcomes of liver resection for hepatitis C-related hepatocellular carcinoma after the introduction of direct-acting antiviral therapy C Rocha, J Di Norcia, P Tabrizian, C Di Renzo, S Amodeo, Y Bekki, ... HPB, 2024 | | 2024 |
| 48 Analyzing Changing Trends in Hepatocellular Carcinoma A Pero, K Sigel, M Schwartz Journal of Clinical and Translational Science 8 (s1), 13-13, 2024 | | 2024 |
| Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma JM Llovet, R Pinyol, M Yarchoan, AG Singal, TU Marron, M Schwartz, ... Nature Reviews Clinical Oncology 21 (4), 294-311, 2024 | 13 | 2024 |
| Prognostic significance of nodular number in patients undergoing hepatectomy of intermediate-stage hepatocellular carcinoma ZQ Fan, M Serenari, X Lv, M Schwartz, W Qiu, TM Pawlik, Z Chen, ... British Journal of Surgery 111 (3), znae047, 2024 | | 2024 |
| Antiviral Therapy Utilization and 10-Year Outcomes in Resected Hepatitis B Virus–and Hepatitis C Virus–Related Hepatocellular Carcinoma DQ Huang, JK Hoang, R Kamal, PC Tsai, H Toyoda, ML Yeh, S Yasuda, ... Journal of Clinical Oncology 42 (7), 790-799, 2024 | 6 | 2024 |
| Racial and ethnic disparities in untreated patients with hepatitis C virus‐related hepatocellular carcinoma but not in those with sustained virologic response JE Park, VH Nguyen, PC Tsai, H Toyoda, J Leong, JE Guy, ML Yeh, ... Alimentary Pharmacology & Therapeutics 59 (6), 742-751, 2024 | | 2024 |
| Is repeat resection for recurrent intrahepatic cholangiocarcinoma warranted? Outcomes of an international analysis ML Holzner, V Mazzaferro, MDD Busset, L Aldrighetti, F Ratti, ... Annals of Surgical Oncology, 1-8, 2024 | 1 | 2024 |
| Impact of underlying liver disease on unresectable hepatocellular carcinoma treated with immune checkpoint inhibitors YL Wu, S Cappuyns, A Loh, S Sun, S Lewis, MW Sung, M Schwartz, ... BJC Reports 2 (1), 8, 2024 | 2 | 2024 |
| Cholangiocarcinoma, sequential chemotherapy, and prognostic tests HW Bruckner, R De Jager, E Knopf, F Bassali, A Book, D Gurell, ... Frontiers in Oncology 14, 2024 | | 2024 |
| Normothermic machine perfusion of marginal grafts in high meld recipients: a NY center experience R Todd, A Rosowicz, M Holzner, A Kressel, G Meyerovich, A Fagenson, ... HPB 26, S729-S730, 2024 | | 2024 |
| Reanimating the hepatectomized liver: a novel use for normothermic machine preservation R Todd, L van Leeuwen, D Puleston, M Holzner, P Tabrizian, J DiNorcia, ... HPB 26, S641, 2024 | | 2024 |
| Early post-treatment MRI predicts long-term hepatocellular carcinoma response to radiation segmentectomy D Stocker, MJ King, ME Homsi, J Gnerre, B Marinelli, M Wurnig, ... European Radiology 34 (1), 475-484, 2024 | | 2024 |
| LBA4 Low-dose stereotactic body radiotherapy prior to pre-operative cemiplimab for patients with resectable hepatocellular carcinoma TU Marron, O Hapanowicz, N Lucas, K Wu, M Buckstein, P Tabrizian, ... Immuno-Oncology and Technology 20, 2023 | | 2023 |
| 170P Targeting myeloid cells in non-small cell lung cancer and hepatocellular carcinoma: A window-of-opportunity trial of nivolumab with BMS-813160 (CCR2/5i) or BMS-986253 … NJ Venturini, P Hamon, S Ward, MI Fiel, MB Beasley, E Kim, ... Immuno-Oncology and Technology 20, 2023 | 1 | 2023 |
| Novel Benchmark Values for Open Major Anatomic Liver Resection in Non-cirrhotic Patients R Sousa da Silva, E Breuer, S Shankar, S Kawakatsu, W Hołówko, ... Lippincott, Williams & Wilkins, 2023 | | 2023 |
